Compare PMTS & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMTS | SGMO |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.4M | 141.2M |
| IPO Year | 2015 | 2000 |
| Metric | PMTS | SGMO |
|---|---|---|
| Price | $13.89 | $0.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $27.67 | $5.75 |
| AVG Volume (30 Days) | 73.8K | ★ 4.3M |
| Earning Date | 03-05-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.89 |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $312,189,000.00 | $36,567,000.00 |
| Revenue This Year | $9.09 | $4.79 |
| Revenue Next Year | $6.79 | N/A |
| P/E Ratio | $11.11 | ★ N/A |
| Revenue Growth | 12.27 | ★ 88.60 |
| 52 Week Low | $10.81 | $0.35 |
| 52 Week High | $30.51 | $0.93 |
| Indicator | PMTS | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 42.57 |
| Support Level | $12.26 | $0.36 |
| Resistance Level | $16.38 | $0.56 |
| Average True Range (ATR) | 1.08 | 0.03 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 32.78 | 12.09 |
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.